International law firm Clifford Chance advised To-Increase, a portfolio company of its long-standing client private equity investor Rivean Capital, on the acquisition of AX for Pharma (AXP) in Italy.
To-Increase is a leading global Independent Software Vendor (ISV) for Microsoft Dynamics 365 (D365) business applications. AXP is another fast-growing Microsoft Dynamics 365 ISV and integrator focused exclusively on SaaS business applications for the pharmaceutical, biotech, and medical device industries. The acquisition of AXP aims to expand To-Increase’s global footprint and strengthen its presence in the process manufacturing vertical. The transaction signed in March and was completed in April.
The Clifford Chance cross-border team was led by Pieter Leefers and consisted of Robin Traas, Ruben van Diepen (Corporate), Michiel Sunderman, Alec Sanderson and Cile Arnoldy (Tax) and Leen Kranenburg (Notary) in Amsterdam, and Milena Raffaldi, Francesco Romagnoli,Antoaneta Shikerova (Corporate), Luciano Di Via, Antonio Mirabile and Luca Borin (Antitrust), Marina Mobiglia (Employment) and Andrea Sgrilli (Tax) in Milan.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
